Search

Hui Yue (Zhejiang University) and colleagues published a new paper on filamentous phages as tumor-targeting immunotherapeutic agents, showing engineered phages can home to tumors and block PD-1/PD-L1 interaction for targeted cancer immunoth

Nanogami (Munich, Germany) is a startup pioneering a novel generation of biochips to unlock applications in research and diagnostics. They’re hiring a Senior Biotechnology Research Scientist, and are seeking candidates with experience with

Michelle Bach (Stanford University) and colleagues published a new preprint on how the filamentous phage Pf (present in 69% of Pseudomonas aeruginosa wounds) delays healing of P. aeruginosa-infected wounds by provoking an anti-phage immune

Michelle Bach (Stanford University) and colleagues published a new preprint on how the filamentous phage Pf (present in 69% of Pseudomonas aeruginosa wounds) delays healing of P. aeruginosa-infected wounds by provoking an anti-phage immune

Johanna Sweere and colleagues just published a very exciting paper today in Science! A temperate filamentous phage of Pseudomonas aeruginosa dampens the immune response against P. aeruginosa, which leads to increased P. aeruginosa virulence

Johanna Sweere and colleagues just published a very exciting paper today in Science! A temperate filamentous phage of Pseudomonas aeruginosa dampens the immune response against P. aeruginosa, which leads to increased P. aeruginosa virulence